4.6 Article

Exogenous hedgehog antagonist delays but does not prevent fracture healing in young mice

Journal

BONE
Volume 103, Issue -, Pages 241-251

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.bone.2017.07.017

Keywords

Fracture healing; Mouse femur fracture; Hedgehog antagonist; Gli1 reporter; Callus bone mineral density

Funding

  1. Washington University Musculoskeletal Research Center [NIH/NIAMS P30 AR057235]
  2. NIH/NIAMS [R21 AR066798]
  3. Orthopaedic Research and Education Foundation (CDA)
  4. Hope Center Alafi Neuroimaging Lab
  5. Neuroscience Blueprint Interdisciplinary Center Core award [P30 NS057105]
  6. NCI Cancer Center Support Grant [P30 CA91842]
  7. ICTS/CTSA from the National Center for Research Resources (NCRR) [UL1TR000448]

Ask authors/readers for more resources

Fracture healing recapitulates many aspects of developmental osteogenesis. The hedgehog (Hh) signaling pathway, essential to skeletal development, is upregulated during fracture healing, although its importance is unclear. Our goal was to assess the functional importance of Hh signaling in endochondral fracture healing. We created closed, transverse diaphyseal femur fractures in mice, stabilized with an intramedullary pin, and administered a systemic Hh inhibitor or vehicle. Because Hh pathway activation is mediated by the receptor Smoothened (Smo), we used the Smo antagonist GDC-0449 (GDC, 50 mg/kg, twice daily) to target the pathway. First, in vehicle-treated 10-wk. female C57BL/6 mice we confirmed that Hh signaling was increased in fracture callus compared to intact bone, with >5-fold upregulation of target genes Ptch1 and Gli1. Additionally, using 10-wk. male and female Gli1 reporter mice, we saw a strong activation of the reporter in the osseous regions of the fracture callus 7-10 days after fracture. GDC treatment significantly blunted these responses, indicating effective inhibition of fracture-induced Hh signaling in bone. Moreover, microCT analysis revealed that GDC treatment significantly reduced cancellous and cortical bone volume at non-fracture sites (tibial metaphysis and diaphysis), suggesting that the drug inhibited normal bone formation. GDC treatment had a modest effect on fracture healing, with evidence of delayed callus mineralization radiographically (significantly lower Goldberg score at day 14) and by microCT (reduced callus vBMD at 14 days), and a delay in the recovery of torsional rotation to normal (elevated rotation-at-peak torque at 21 days). On the other hand, GDC treatment did not inhibit qPCR or morphological measures of chondrogenesis or angiogenesis, and did not impair the recovery of failure torque (at day 14 or 21), a measure of biomechanical competence. In summary, GDC treatment inhibited Hh signaling, which delayed but did not prevent fracture healing in young mice. We conclude that Hh signaling is strongly induced after fracture and may play a role in early callus mineralization, although it does not appear to be required for eventual healing. (C) 2017 Elsevier Inc All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available